General Information
Revision date
2022-11-16
Product name
Rapamycin, mTORC1 complex inhibitor
Substance name
Pure substance/mixture
CAS No.
53123-88-9
1.2.1 Relevant identified uses
For research use only. Not for use in diagnostic procedures
Icons in SDS
Company Information
company name
Abcam Australia Pty. Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
au.technical@abcam.com, sds@abcam.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H351, H361, H372
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
GHS Classification Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 2 - (H361) Specific target organ toxicity (repeated exposure) Category 1 - (H372) Label elements
Signal word
DANGER Hazard statements H351 - Suspected of causing cancer H361 - Suspected of damaging fertility or the unborn child H372 - Causes damage to organs through prolonged or repeated exposure Precautionary Statements - Prevention Obtain special instructions before use Do not handle until all safety precautions have been read and understood Wear protective gloves/clothing and eye/face protection Do not breathe dust/fume/gas/mist/vapours/spray Wash face, hands and any exposed skin thoroughly after handling Do not eat, drink or smoke when using this product Precautionary Statements - Response IF exposed or concerned: Get medical advice/attention Precautionary Statements - Storage Store locked up
Precautionary statements
Disposal Dispose of contents/container to an approved waste disposal plant
Other hazards which do not result in classification
Caution - substance not yet tested completely.
2.1 Classification of the substance or mixture
Category 2 - (H351) Reproductive toxicity Category 2 - (H361) Specific target organ toxicity (repeated exposure) Category 1 - (H372) Label elements
